Published in Health Insurance Law Weekly, August 14th, 2005
CHAVI will receive $15 million in its first year and may receive more than $300 million in total over 7 years, according to NIAID, part of the National Institutes of Health (NIH). CHAVI's mission is to address major obstacles to HIV vaccine development and to design, develop and test novel HIV vaccine candidates. The award...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.